Using urine analysis to help diagnose bladder cancer
Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancer
This study is testing if a new way of analyzing urine can help doctors better detect bladder cancer early in people at risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | CHU de Reims Academic / other |
| Locations | 1 site (Reims) |
| Trial ID | NCT06087016 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of vibrational spectroscopy techniques, specifically Infrared and Raman spectroscopy, in diagnosing bladder cancer through urine samples. Given the high recurrence and progression rates of bladder cancer, the study aims to develop a non-invasive and sensitive diagnostic tool that could improve early detection. Participants will provide urine samples and complete a questionnaire to gather clinical information, with the study planned to last for 36 months.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are undergoing a urology consultation for cystoscopy.
Not a fit: Patients who have refused to participate, lack a native bladder, or have a bladder fistula will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier and more accurate diagnosis of bladder cancer, reducing the need for invasive procedures.
How similar studies have performed: While the use of vibrational spectroscopy in medical diagnostics is promising, this specific application for bladder cancer diagnosis is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
inclusion criteria: * Must be over 18 years of age * Able to give consent and understand the purpose the study * Agree to participate in the study and having signed the non-objection document * Admitted to a urology consultation for cystoscopy exclusion criteria: Patients with any of the following criteria will not be included in the study * Refused to participate in the study or unable to give consent * without a native bladder * with a bladder fistula
Where this trial is running
Reims
- Damien JOLLY — Reims, France (Recruiting)
Study contacts
- Study coordinator: Stéphane LARRE
- Email: slarre@chu-reims.fr
- Phone: 03 26 78 94 24
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.